Newly Diagnosed Type 1 Diabetes Presenting with Diabetic Ketoacidosis After SARS-CoV-2 Vaccine

Kose M., ANAFOROĞLU İ.

TURKISH JOURNAL OF ENDOCRINOLOGY AND METABOLISM, vol.27, no.1, pp.33-35, 2023 (ESCI) identifier identifier

  • Publication Type: Article / Article
  • Volume: 27 Issue: 1
  • Publication Date: 2023
  • Doi Number: 10.5152/erp.2023.22125
  • Journal Name: TURKISH JOURNAL OF ENDOCRINOLOGY AND METABOLISM
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, Academic Search Premier, CINAHL, EMBASE, Directory of Open Access Journals, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.33-35
  • Acibadem Mehmet Ali Aydinlar University Affiliated: Yes

Abstract

The COVID-19 pandemic has deeply affected the whole world in the last 3 years due to the mortality and morbidity it causes. Billions of doses of vaccines have been administered to overcome the pan-demic. The increased incidence of various autoimmune diseases during the pandemic has given rise to the thought that COVID-19 infection or vaccine may be the triggering factor. Recently, new-onset autoimmune phenomena after COVID-19 vaccination have been reported for some autoimmune dis-eases like Guillain-Barre syndrome and other neurological autoimmune diseases, IgA nephropathy, rheumatoid arthritis and systemic lupus erythematosus, immune thrombotic thrombocytopenia, autoimmune liver diseases, and autoimmune thyroid diseases. Here, we present a case of newly diag-nosed type 1 diabetes that developed 1 month after the SARS-CoV-2 vaccine.